Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Pots JM"'
Autor:
Bol KF; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Schreibelt G; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Bloemendal M; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., van Willigen WW; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Hins-de Bree S; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., de Goede AL; Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands., de Boer AJ; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Bos KJH; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Duiveman-de Boer T; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Olde Nordkamp MAM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., van Oorschot TGM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Popelier CJ; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Pots JM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Scharenborg NM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., van de Rakt MWMM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., de Ruiter V; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., van Meeteren WS; Department of Dermatology, Radboud university medical center, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud university medical center, Nijmegen, The Netherlands., Croockewit SJ; Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands., Koeneman BJ; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Creemers JHA; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Wortel IMN; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands., Angerer C; Miltenyi Biotec, Bergisch Gladbach, Germany., Brüning M; Miltenyi Biotec, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec, Bergisch Gladbach, Germany., Dzionek A; Miltenyi Biotec, Bergisch Gladbach, Germany., van der Veldt AA; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., van Grünhagen DJ; Department Surgical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Werner JEM; Department Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Bonenkamp JJ; Department Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Haanen JBAG; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Boomsma MF; Department of Radiology, Isala Oncology Center, Zwolle, The Netherlands., Aarntzen EHJ; Department of Medical Imaging, Radboud university medical center, Nijmegen, The Netherlands., Gotthardt M; Department of Medical Imaging, Radboud university medical center, Nijmegen, The Netherlands., Nagarajah J; Department of Medical Imaging, Radboud university medical center, Nijmegen, The Netherlands., de Witte TJM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Figdor CG; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., de Wilt JHW; Department Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Textor J; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands., de Groot JWB; Department of Medical Oncology, Isala Oncology Center, Zwolle, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., de Vries IJM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands. Jolanda.deVries@radboudumc.nl.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 23; Vol. 15 (1), pp. 1632. Date of Electronic Publication: 2024 Feb 23.
Autor:
Schreibelt G; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands. Electronic address: gerty.schreibelt@radboudumc.nl., Duiveman-de Boer T; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., Pots JM; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., van Oorschot TGM; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., de Boer AJ; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., Scharenborg NM; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., van de Rakt MWMM; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., Bos K; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands., de Goede AL; Department of Pharmacy, Radboudumc, Nijmegen, The Netherlands., Petry K; Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany., Brüning M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Angerer C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Schöggl C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Dzionek A; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., de Vries IJM; Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Publikováno v:
Methods in cell biology [Methods Cell Biol] 2024; Vol. 183, pp. 33-50. Date of Electronic Publication: 2023 Sep 15.
Autor:
Boudewijns S; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Westdorp H; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Textor JC; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center , Nijmegen, the Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Pots JM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van Meeteren WS; Department of Dermatology, Radboud University Medical Center , Nijmegen, the Netherlands., van der Graaf WT; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom., Bonenkamp JJ; Department of Surgical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands., de Wilt JH; Department of Surgical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center , Amsterdam, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center Nijmegen , Nijmegen, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., de Vries IJ; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 May 31; Vol. 5 (7), pp. e1191732. Date of Electronic Publication: 2016 May 31 (Print Publication: 2016).
Autor:
Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Westdorp H; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Wimmers F; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Tel J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Winkels G; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Blokx WA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Welzen ME; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Mus RD; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Jacobs JF; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Kelderman S; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Blank CU; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. jolanda.devries@radboudumc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 May 01; Vol. 22 (9), pp. 2155-66. Date of Electronic Publication: 2015 Dec 28.
Autor:
Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands., Blokx WA; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands., Oyen WJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Mus RD; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands., van der Graaf CA; Department of Pulmonary Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Centre, Amsterdam, The Netherlands., Adema GJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Gerty.Schreibelt@radboudumc.nl.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2016 Mar; Vol. 65 (3), pp. 327-39. Date of Electronic Publication: 2016 Feb 10.
Autor:
Bol KF; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands ; Medical Oncology; Radboud university medical centre ; Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Aarntzen EH; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands ; Radiology and Nuclear Medicine; Radboud university medical centre ; Nijmegen, The Netherlands., Welzen ME; Pharmacy; Radboud university medical centre ; Nijmegen, The Netherlands., van Rossum MM; Dermatology; Radboud university medical centre ; Nijmegen, The Netherlands., Blokx WA; Pathology; Radboud university medical centre ; Nijmegen, The Netherlands., van de Rakt MW; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Scharenborg NM; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., de Boer AJ; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Pots JM; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Olde Nordkamp MA; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., van Oorschot TG; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Mus RD; Radiology and Nuclear Medicine; Radboud university medical centre ; Nijmegen, The Netherlands., Croockewit SA; Hematology; Radboud university medical centre ; Nijmegen, The Netherlands., Jacobs JF; Laboratory Medicine; Radboud university medical centre ; Nijmegen, The Netherlands., Schuler G; Department of Dermatology; University Hospital Erlangen ; Erlangen, Germany., Neyns B; Department of Medical Oncology; Vrije Universiteit Brussel ; Brussels, Belgium., Austyn JM; Nuffield Department of Surgical Sciences; John Radcliffe Hospital; University of Oxford ; Oxford, UK., Punt CJ; Department of Medical Oncology; Academic Medical Center ; Amsterdam, The Netherlands., Schreibelt G; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., de Vries IJ; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands ; Medical Oncology; Radboud university medical centre ; Nijmegen, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2015 Apr 01; Vol. 4 (8), pp. e1019197. Date of Electronic Publication: 2015 Apr 01 (Print Publication: 2015).
Autor:
Prinsen H; a Department of Medical Oncology; Radboud University Medical Center ; Nijmegen , the Netherlands., van Laarhoven HW, Pots JM, Duiveman-de Boer T, Mulder SF, van Herpen CM, Jacobs JF, Leer JW, Bleijenberg G, Stelma FF, Torensma R, de Vries IJ
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2015; Vol. 11 (7), pp. 1634-40.
Autor:
Prinsen H; Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, the Netherlands. h.prinsen@onco.umcn.nl, de Vries IJ, Torensma R, Pots JM, Mulder SF, van Herpen CM, Elving LD, Bleijenberg G, Stelma FF, van Laarhoven HW
Publikováno v:
BMC immunology [BMC Immunol] 2012 Dec 17; Vol. 13, pp. 71. Date of Electronic Publication: 2012 Dec 17.
Autor:
Cruz LJ; Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Geert Grooteplein 28, 6525 GA, Nijmegen, The Netherlands., Tacken PJ, Pots JM, Torensma R, Buschow SI, Figdor CG
Publikováno v:
Biomaterials [Biomaterials] 2012 Jun; Vol. 33 (16), pp. 4229-39. Date of Electronic Publication: 2012 Mar 10.
Autor:
Yigit R; Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands., Figdor CG, Zusterzeel PL, Pots JM, Torensma R, Massuger LF
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2011 Aug; Vol. 47 (12), pp. 1883-9. Date of Electronic Publication: 2011 Apr 20.